表紙:ポリメラーゼ連鎖反応の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年-2026年)
市場調査レポート
商品コード
1029094

ポリメラーゼ連鎖反応の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年-2026年)

Polymerase Chain Reaction Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 140 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
ポリメラーゼ連鎖反応の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年-2026年)
出版日: 2021年09月16日
発行: IMARC Services Private Limited
ページ情報: 英文 140 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポリメラーゼ連鎖反応市場規模は、2015年から2020年にかけて力強い成長を示し、2021年から2026年にかけて約8%のCAGRで成長すると予測されています。

ポリメラーゼ連鎖反応(PCR)とは、DNAの断片を複数コピーするために使用される分子診断技術を指します。PCR装置を用いて、あらかじめプログラムされた自動手順でサンプルの温度を操作し、数百万のDNAのコピーを正確に配列します。この技術は、病気の原因となる微生物を特定し培養するもので、結核、後天性免疫不全症候群(AIDS)、感染症、ライム病などの検出に役立ちます。そのため、遺伝学、バイオテクノロジー、分子生物学、創薬、臨床診断など、ライフサイエンスに関連する様々な分野で幅広く利用されています。

市場の成長を促す重要な要因の一つは、様々な感染症や遺伝性疾患の増加です。慢性的な病気にかかりやすい高齢者人口が世界的に増加していることも、業界の成長を後押ししています。さらに、コロナウイルス感染症(COVID-19)のパンデミック発生により、感染症の正確な診断と早期発見のためにPCR技術が広く採用されるようになりました。また、PCR装置は、汚染のリスクやプロセス全体における人的エラーの可能性を最小限に抑えることができます。

当レポートでは、世界のポリメラーゼ連鎖反応市場について調査分析し、世界市場、製品別、エンドユーザー別、地域別市場セグメンテーション、SWOT分析、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競合情勢、企業プロファイルを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のポリメラーゼ連鎖反応市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響

第6章 市場セグメンテーション:製品別

  • 器具
  • 試薬と消耗品
  • ソフトウェアとサービス

第7章 市場セグメンテーション:エンドユーザー別

  • 学術調査機関
  • 臨床診断ラボおよび病院
  • 製薬およびバイオテクノロジー企業
  • その他

第8章 市場セグメンテーション:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 市場セグメンテーション:国別

第9章 SWOT分析

第10章 バリューチェーン分析

第11章 ポーターズファイブフォース分析

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • キープレーヤー
  • キープレーヤーのプロファイル
    • Agilent Technologies Inc.
    • BD(Becton, Dickinson and Company)
    • BioMerieux(Institut Merieux SA)
    • Bio-RAD Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Fluidigm Corporation
    • Merck KGaA
    • Perkinelmer Inc.
    • Promega Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Polymerase Chain Reaction Market: Major Drivers and Challenges
  • Figure 2: Global: Polymerase Chain Reaction Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Polymerase Chain Reaction Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Polymerase Chain Reaction Market: Breakup by End User (in %), 2020
  • Figure 5: Global: Polymerase Chain Reaction Market: Breakup by Region (in %), 2020
  • Figure 6: Global: Polymerase Chain Reaction Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 7: Global: Polymerase Chain Reaction (Instruments) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 8: Global: Polymerase Chain Reaction (Instruments) Market: Breakup by Instrument Type (in %), 2020
  • Figure 9: Global: Polymerase Chain Reaction (Instruments- Standard PCR Systems) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 10: Global: Polymerase Chain Reaction (Instruments- Standard PCR Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 11: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Polymerase Chain Reaction (Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Polymerase Chain Reaction (Reagents and Consumables) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Polymerase Chain Reaction (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Polymerase Chain Reaction (Software and Services) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Polymerase Chain Reaction (Software and Services) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Polymerase Chain Reaction (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Polymerase Chain Reaction (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: North America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: North America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: United States: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: United States: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Canada: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Canada: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Asia Pacific: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Asia Pacific: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: China: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: China: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Japan: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Japan: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: India: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: India: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: South Korea: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: South Korea: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Australia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Australia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Indonesia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: Indonesia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Europe: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Europe: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: Germany: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: Germany: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: France: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: France: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: United Kingdom: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: United Kingdom: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: Italy: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Italy: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: Spain: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: Spain: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Russia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Russia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Latin America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Latin America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Brazil: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Brazil: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: Mexico: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: Mexico: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Middle East and Africa: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Middle East and Africa: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: Global: Polymerase Chain Reaction Industry: SWOT Analysis
  • Figure 77: Global: Polymerase Chain Reaction Industry: Value Chain Analysis
  • Figure 78: Global: Polymerase Chain Reaction Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Polymerase Chain Reaction Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Polymerase Chain Reaction Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Polymerase Chain Reaction Market Forecast: Breakup by End User (in Million US$), 2021-2026
  • Table 4: Global: Polymerase Chain Reaction Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 5: Global: Polymerase Chain Reaction Market Structure
  • Table 6: Global: Polymerase Chain Reaction Market: Key Players
目次
Product Code: SR1020F44_Report

The global polymerase chain reaction market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Polymerase chain reaction (PCR) refers to a molecular diagnostic technique that is used to make multiple copies of a segment of DNA. A PCR machine is used to manipulate the temperature of the sample in an automatic and pre-programmed procedure to generate millions of copies of DNA sequencing accurately. This technology identifies and cultures disease-causing microorganisms, which aid in the detection of tuberculosis, Acquired Immunodeficiency Syndrome (AIDS), infections and Lyme disease. Owing to this, it finds extensive applications across various life science-related fields, such as genetics, biotechnology, molecular biology, drug discovery and clinical diagnostics.

Global Polymerase Chain Reaction Market Trends and Drivers:

  • The increasing prevalence of various infectious diseases and genetic disorders is one of the key factors driving the growth of the market. The rising geriatric population across the globe, which is more prone to chronic medical ailments, is also driving the industry growth. The outbreak of the coronavirus disease (COVID-19) pandemic has further led to the widespread adoption of PCR technologies for accurate diagnosis and early detection of infections. PCR devices also aid in minimizing the risks of contamination and the chances of human errors in the entire process.
  • The increasing demand for personalized and precision medicines is also creating a positive outlook for the market. These medicines aim to provide tailor-made therapies, which are identified and developed using PCR technologies. Other factors, including the increasing application in clinical diagnostics, along with extensive research and development (R&D) activities in the field of biotechnology, are expected to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global polymerase chain reaction market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, end user and region.

Breakup by Product:

  • Instruments
  • Standard PCR Systems
  • Digital PCR Systems
  • Real-time PCR Systems
  • Reagents and Consumables
  • Software and Services

Breakup by End User:

  • Academic and Research Institutes
  • Clinical Diagnostics Labs and Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., BD (Becton, Dickinson and Company), BioMerieux (Institut Merieux SA), Bio-RAD Laboratories Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Merck KGaA, Perkinelmer Inc., Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:

  • How has the global polymerase chain reaction market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global polymerase chain reaction market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global polymerase chain reaction market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Polymerase Chain Reaction Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Standard PCR Systems
      • 6.1.2.1.1 Market Trends
      • 6.1.2.1.2 Market Forecast
      • 6.1.2.2 Digital PCR Systems
      • 6.1.2.2.1 Market Trends
      • 6.1.2.2.2 Market Forecast
      • 6.1.2.3 Real-Time PCR Systems
      • 6.1.2.3.1 Market Trends
      • 6.1.2.3.2 Market Forecast
    • 6.1.3 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Academic and Research Institutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Diagnostics Labs and Hospitals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pharmaceutical and Biotechnology Companies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BD (Becton, Dickinson and Company)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 BioMerieux (Institut Merieux SA)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-RAD Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Fluidigm Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Perkinelmer Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Promega Corporation
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Takara Bio Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis